Obesity and Diet Imbalance

About Conference

We are delighted to invite you to the 9th International Conference on Obesity and Diet Imbalance (OBESITY DIET 2026), scheduled to take place in the vibrant city of London, UK, on June 25–26, 2026. Held under the theme “Global Approaches to Combating Obesity and Diet Imbalance,” this prestigious event promises to be a dynamic gathering of thought leaders, innovators, and global experts.

Conferences like OBESITY DIET 2026 serve as essential platforms for uniting the global scientific community, healthcare practitioners, industry pioneers, and policy influencers. The event will feature powerful keynote presentations, engaging panel discussions, hands-on technical workshops, poster exhibitions, and outstanding networking opportunities to inspire collaboration and accelerate progress.

We are proud to welcome an outstanding roster of internationally acclaimed speakers and visionaries who will address urgent issues in obesity, metabolic health, dietary behaviors, and public nutrition policy. The program will highlight cutting-edge research in obesity prevention, clinical care, food systems, behavioral science, and technological advancements in weight management. Whether you are a researcher, healthcare professional, academic, policymaker, or student, this conference offers a unique opportunity to share your work, discover innovative solutions, and build lasting connections across disciplines. Join us in London as we come together to shape the future of obesity research and nutrition science through shared knowledge and transformative collaboration.

Tracks

Track 01: Childhood Obesity and Early-Life Nutrition

Explores the causes and consequences of childhood obesity, highlighting the role of early-life nutrition, feeding behaviors, and family environment. This track focuses on prevention strategies, educational interventions, and long-term health outcomes related to excessive weight gain during critical developmental periods in children and adolescents.

Track 02:  Genetics and Epigenetics of Obesity

Examines the genetic predispositions and epigenetic modifications contributing to obesity. Discussions include gene-environment interactions, obesity-related gene expression, and how inherited and lifestyle factors influence metabolism, appetite, and fat distribution, paving the way for personalized approaches in obesity treatment and prevention.

Track 03: Obesity and Metabolic Syndrome

Focuses on the link between obesity and metabolic syndrome, covering insulin resistance, hypertension, dyslipidemia, and cardiovascular risk. This track explores how obesity triggers these metabolic disturbances and how integrated interventions can mitigate associated long-term health complications.

Track 04: Nutritional Interventions for Obesity

Presents evidence-based dietary approaches to prevent and manage obesity, including calorie restriction, macronutrient balance, intermittent fasting, and plant-based diets. This track assesses nutritional adequacy, sustainability, and effectiveness in promoting weight loss and improving metabolic health.

Track 05: Role of the Gut Microbiome in Obesity

Explores how gut microbiota composition influences energy metabolism, fat storage, inflammation, and appetite regulation. Topics include probiotics, prebiotics, microbiome-targeted diets, and fecal microbiota transplantation as potential strategies in managing obesity and restoring gut health.

Track 06: Physical Activity and Weight Management

Highlights the role of physical activity and structured exercise programs in obesity prevention and treatment. This track also examines sedentary behavior, energy expenditure, and tailored movement therapies to support healthy body weight and metabolic function.

Track 07: Hormonal Regulation and Obesity

Covers how hormones like leptin, insulin, ghrelin, and cortisol influence hunger, fat storage, and metabolism. This track discusses hormonal imbalances in obesity, endocrine-disrupting chemicals, and therapeutic options targeting hormonal pathways for weight regulation.

Track 08: Obesity and Type 2 Diabetes

Investigates the strong association between obesity and type 2 diabetes, emphasizing the role of adiposity in insulin resistance. This track includes preventive strategies, lifestyle modifications, and integrated treatment options to manage both conditions simultaneously.

Track 09: Behavioral and Psychological Aspects of Obesity

Focuses on the psychological dimensions of obesity including eating disorders, body image issues, emotional eating, and motivation. Cognitive-behavioral therapy, mindfulness, and behavior modification strategies are explored for sustainable lifestyle change.

Track 10: Obesity and Cardiovascular Disease

Examines the impact of obesity on cardiovascular risk factors such as atherosclerosis, hypertension, and heart failure. This track discusses pathophysiological mechanisms and how weight management improves heart health outcomes.

Track 11: Pharmacotherapy for Obesity

Covers current and emerging anti-obesity medications, their mechanisms of action, benefits, and side effects. The track also discusses how pharmacological treatments can complement lifestyle changes for effective weight reduction.

Track 12: Bariatric Surgery and Long-Term Outcomes

Explores different bariatric procedures, including gastric bypass and sleeve gastrectomy. Topics include patient selection, postoperative care, nutritional deficiencies, psychological support, and the long-term success of surgical interventions for severe obesity.

Track 13: Obesity in Women’s Health

Examines how obesity uniquely affects women's reproductive health, fertility, pregnancy outcomes, and menopause. This track also addresses gender-specific interventions and hormonal considerations in managing weight in women.

Track 14: Public Health Strategies for Obesity Prevention

Focuses on population-level approaches to address obesity through policy, education, urban design, and food labeling. This track evaluates successful national and global initiatives and their impact on public health outcomes.

Track 15: Socioeconomic Determinants of Diet and Obesity

Analyzes how poverty, food insecurity, education, and urbanization influence dietary patterns and obesity rates. This track advocates for addressing inequality and promoting access to healthy foods and environments.

Track 16: Digital Health and Weight Management

Covers the use of mobile apps, wearables, telehealth, and artificial intelligence in tracking diet, activity, and behavioral change. It explores how digital tools enhance personalized obesity management and long-term adherence.

Track 17: Obesity and Cancer Risk

Discusses the evidence linking obesity to increased risk for cancers such as breast, colorectal, and endometrial. Mechanisms include inflammation, hormone imbalances, and insulin resistance, with emphasis on prevention and early detection.

Track 18: Dietary Fats, Sugars, and Obesity

Examines the role of saturated fats, trans fats, added sugars, and ultra-processed foods in promoting obesity. This track offers insights into dietary guidelines and public health messaging around sugar and fat consumption.

Track 19: Obesity in Aging Populations

Explores how obesity affects older adults, including impacts on mobility, frailty, cognitive decline, and chronic disease. Tailored interventions for weight management in aging populations are discussed, along with nutrient-dense dietary planning.

Track 20: Cultural Perspectives on Diet and Obesity

Considers how cultural beliefs, traditional diets, and regional eating habits influence obesity prevalence. This track promotes culturally sensitive approaches to nutritional counseling, community programs, and behavior change.

Participation Benefits

Benefits of Participation for Speakers

• Researchers are recognized globally for their contributions.

• Obtain credits for professional development.

• Explore cutting-edge analysis.

• Foster long-term relationships through social and networking events.

• Successfully promoted one page in abstract books and flyers, resulting in 1 million views and enhancing

   your research profile.

• Explore topics beyond Cell and Gene Therapy to broaden your knowledge and understanding.

• Our unique offering combines networking, learning, and enjoyment.

Benefits of Participation for Delegates

• Professional Development: Enhance understanding and knowledge.

• Attending webinars helps delegates feel supported, rejuvenated, and energized.

• Participating in our webinar will contribute to a new approach and ideology that can improve business and industry outcomes.

• Online webinars provide opportunities for researchers and specialists in Obesity and Diet Imbalance to connect and share ideas.

Benefits of Participation for Sponsor

• Exposure to international markets may lead to the formation of new enterprises.

• Demonstrate your company's latest innovations, products, and services to worldwide attendees.

• Generate leads to increase business for our participants.

• Webinars on Obesity and Diet Imbalance offer valuable insights to propel your firm forward.

• Advancing organizational plans through benchmarking.

• Attend our webinar to receive trustworthy input on your company's problems and challenges.

• Use your company's branding, marketing content, and advertising logo on webinar banners, websites, and other materials.

Benefits of the Association for Collaborators

• Developing long-term peer ties.

• Adding your organization's logo to our webinar banner, website, and other marketing materials can increase subscriber/membership by 40%.

• Our event will increase your company's visibility in the Global Business Forum, benefiting your association significantly.

• Representatives can enhance their knowledge of your organization and services by networking with key webinar delegates.

• Advertising materials for Obesity and Diet Imbalance, including posters, brochures, and pamphlets, will include information for distribution to hospitals, universities, societies, and researchers.

Market Analysis

Obesity and diet-related disorders have reached alarming levels globally, becoming one of the most critical health issues of the 21st century. According to the World Health Organization, more than 1 billion individuals are currently obese, including over 340 million children and adolescents. This growing health crisis contributes significantly to the global burden of no communicable diseases such as diabetes, cardiovascular disease, and certain cancers.

The economic impact is equally concerning. Obesity-related healthcare costs now exceed USD 2 trillion annually, nearly 3% of the global GDP. In the United Kingdom alone, the National Health Service (NHS) spends over £6.5 billion per year addressing obesity-related conditions, a figure projected to rise substantially by 2030 if current trends continue.

Despite these challenges, the market for innovative solutions in obesity and nutrition is rapidly growing. The anti-obesity drug market, valued at USD 7 billion in 2023, is forecasted to reach USD 17.5 billion by 2030. Meanwhile, the clinical nutrition market is expected to grow from USD 50 billion in 2023 to USD 87 billion by 2030. Driving this growth are emerging trends in personalized nutrition, AI-based weight management tools, and behavioral health interventions.